BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ushio R, Murakami S, Saito H. Predictive Markers for Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer. JCM 2022;11:1855. [DOI: 10.3390/jcm11071855] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Möller M, Turzer S, Ganchev G, Wienke A, Schütte W, Seliger B, Riemann D. Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade. Cancers 2022;14:3690. [DOI: 10.3390/cancers14153690] [Reference Citation Analysis]
2 Pirlog R, Chiroi P, Rusu I, Jurj AM, Budisan L, Pop-Bica C, Braicu C, Crisan D, Sabourin JC, Berindan-Neagoe I. Cellular and Molecular Profiling of Tumor Microenvironment and Early-Stage Lung Cancer. Int J Mol Sci 2022;23:5346. [PMID: 35628157 DOI: 10.3390/ijms23105346] [Reference Citation Analysis]